EDGAR Filing Documents for 0001171843-17-004114

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-17-004114

Filing Date

2017-07-17

Accepted

2017-07-17 09:01:30

Documents

Period of Report

2017-07-17

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_071717.htm	6-K	11360
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	8673
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	262002
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	1111
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	1180
6	GRAPHIC	image_005.jpg	GRAPHIC	213385
7	GRAPHIC	image_009.gif	GRAPHIC	9245
8	GRAPHIC	exh993_1.jpg	GRAPHIC	179828
9	GRAPHIC	exh993_2.jpg	GRAPHIC	179200
10	GRAPHIC	exh994_1.jpg	GRAPHIC	205565
11	GRAPHIC	exh994_2.jpg	GRAPHIC	170615
	Complete submission text file	0001171843-17-004114.txt		1597148

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)